0001104659-26-053515
SEC filingSenseonics priced an $80 million public offering of common stock and pre-funded warrants and announced a non-binding term sheet to expand its Hercules debt facility to $140 million.
Senseonics Holdings announced a significant financing transaction, pricing an underwritten public offering of 8 million shares of common stock and 8 million pre-funded warrants at $5.00 per share. The offering is expected to generate net proceeds of approximately $74.7 million, which the company intends to use to fund the ongoing launch of Eversense 365, continued development of pipeline products, and for working capital and general corporate purposes. The concurrent announcement of a non-binding term sheet with Hercules Capital to amend its existing loan facility suggests a strategic effort to bolster the balance sheet. If consummated, the Second Amendment would increase the maximum borrowing capacity from $100 million to $140 million, providing an additional $20 million in near-term loan commitments. This capital injection is critical as the company reported preliminary Q1 2026 results showing revenue of $11.7 million against a net loss of $31 million to $33 million. The company held $64.6 million in cash and equivalents as of March 31, 2026. The financing activities appear designed to support the commercial expansion of the Eversense 365 system and the transition of commercial responsibilities from Ascensia.